EdgarLookup

Gossamer Bio, Inc. — All Filings

422 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 305B2 4 4/A 424B3 424B4 424B5 8-A12B 8-K ARS CERT CORRESP CT ORDER D DEF 14A DEFA14A DEL AM DRS DRS/A DRSLTR EFFECT FWP POS AM POSASR PRE 14A RW S-1 S-1/A S-1MEF S-3 S-3ASR S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
S-8 S-8 0001728117-24-000020 Mar 5, 2024
8-K 8-K 0001728117-24-000018 Mar 5, 2024
10-K 10-K 0001728117-24-000019 Mar 5, 2024 Dec 31, 2023
8-K 8-K 0001728117-24-000013 Mar 4, 2024
SC 13G/A GOSSAMER BIO, INC. 0000902664-24-001739 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-021039 Feb 13, 2024
SC 13G 0000315066-24-001145 Feb 9, 2024
SC 13G/A ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO -- SCH 13G/A(#1-EXIT) 0001072613-24-000116 Feb 9, 2024
SC 13G/A 0001273087-24-000008 Jan 11, 2024
SC 13G SC 13G 0001193125-24-006630 Jan 11, 2024
4 FORM 4 0001728117-24-000010 Jan 4, 2024 Jan 2, 2024
4 FORM 4 0001728117-24-000008 Jan 4, 2024 Jan 2, 2024
4 FORM 4 0001728117-24-000002 Jan 4, 2024 Jan 2, 2024
4 FORM 4 0001728117-24-000004 Jan 4, 2024 Jan 2, 2024
4 FORM 4 0001728117-24-000006 Jan 4, 2024 Jan 2, 2024
3 FORM 3 0001728117-23-000163 Dec 5, 2023 Dec 4, 2023
4 FORM 4 0001728117-23-000164 Dec 5, 2023 Dec 4, 2023
3 FORM 3 0001728117-23-000158 Nov 29, 2023 Nov 28, 2023
4 FORM 4 0001728117-23-000160 Nov 29, 2023 Nov 28, 2023
8-K 8-K 0001728117-23-000157 Nov 29, 2023 Nov 28, 2023
8-K 8-K 0001728117-23-000151 Nov 27, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000145 Nov 22, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000146 Nov 22, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000144 Nov 22, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000147 Nov 22, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000148 Nov 22, 2023 Nov 20, 2023
4 FORM 4 0001728117-23-000138 Nov 17, 2023 Nov 15, 2023
4 FORM 4 0001728117-23-000136 Nov 14, 2023 Nov 13, 2023
10-Q 10-Q 0001728117-23-000134 Nov 9, 2023 Sep 30, 2023
8-K 8-K 0001728117-23-000133 Nov 9, 2023
8-K 8-K 0001728117-23-000129 Oct 20, 2023 Oct 19, 2023
8-K 8-K 0001728117-23-000127 Sep 7, 2023 Sep 6, 2023
EFFECT 9999999995-23-002516 Aug 28, 2023
424B3 424B3 0001728117-23-000124 Aug 28, 2023
CORRESP 0001728117-23-000121 Aug 24, 2023
UPLOAD 0000000000-23-009357 Aug 24, 2023
DEL AM DEL AM 0001728117-23-000118 Aug 21, 2023
RW RW 0001728117-23-000114 Aug 18, 2023
S-3 S-3 0001728117-23-000116 Aug 18, 2023
S-3ASR S-3ASR 0001728117-23-000112 Aug 17, 2023
8-K 8-K 0001728117-23-000107 Aug 8, 2023
10-Q 10-Q 0001728117-23-000108 Aug 8, 2023 Jun 30, 2023
D 0001567619-23-006809 Aug 7, 2023
SC 13D GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / GOSSAMER BIO, INC. -- SCHEDULE 13D 0001072613-23-000402 Jul 28, 2023
4 FORM 4 0001728117-23-000099 Jul 26, 2023 Jul 24, 2023
4 FORM 4 0001728117-23-000098 Jul 26, 2023 Jul 24, 2023
4 FORM 4 0001728117-23-000100 Jul 26, 2023 Jul 24, 2023
8-K 8-K 0001728117-23-000091 Jul 20, 2023
8-K 8-K 0001728117-23-000094 Jul 20, 2023 Jul 19, 2023
4 FORM 4 0001728117-23-000086 Jun 26, 2023 Jun 22, 2023